• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用肽景观抗原表位比对工具定量 HLA-DM 依赖的主要组织相容性复合物 II 免疫肽组。

Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.

机构信息

Protein Biochemistry, Institute for Biochemistry, Freie Universität Berlin, Berlin, Germany.

Computational Molecular Biology Group, Institute for Mathematics, Freie Universität Berlin, Berlin, Germany.

出版信息

Front Immunol. 2018 May 3;9:872. doi: 10.3389/fimmu.2018.00872. eCollection 2018.

DOI:10.3389/fimmu.2018.00872
PMID:29774024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5943503/
Abstract

The major histocompatibility complex of class II (MHCII) immunopeptidome represents the repertoire of antigenic peptides with the potential to activate CD4 T cells. An understanding of how the relative abundance of specific antigenic epitopes affects the outcome of T cell responses is an important aspect of adaptive immunity and offers a venue to more rationally tailor T cell activation in the context of disease. Recent advances in mass spectrometric instrumentation, computational power, labeling strategies, and software analysis have enabled an increasing number of stratified studies on HLA ligandomes, in the context of both basic and translational research. A key challenge in the case of MHCII immunopeptidomes, often determined for different samples at distinct conditions, is to derive quantitative information on consensus epitopes from antigenic peptides of variable lengths. Here, we present the design and benchmarking of a new algorithm [peptide landscape antigenic epitope alignment utility (PLAtEAU)] allowing the identification and label-free quantification (LFQ) of shared consensus epitopes arising from series of nested peptides. The algorithm simplifies the complexity of the dataset while allowing the identification of nested peptides within relatively short segments of protein sequences. Moreover, we apply this algorithm to the comparison of the ligandomes of cell lines with two different expression levels of the peptide-exchange catalyst HLA-DM. Direct comparison of LFQ intensities determined at the peptide level is inconclusive, as most of the peptides are not significantly enriched due to poor sampling. Applying the PLAtEAU algorithm for grouping of the peptides into consensus epitopes shows that more than half of the total number of epitopes is preferentially and significantly enriched for each condition. This simplification and deconvolution of the complex and ambiguous peptide-level dataset highlights the value of the PLAtEAU algorithm in facilitating robust and accessible quantitative analysis of immunopeptidomes across cellular contexts. analysis of the peptides enriched for each HLA-DM expression conditions suggests a higher affinity of the pool of peptides isolated from the high DM expression samples. Interestingly, our analysis reveals that while for certain autoimmune-relevant epitopes their presentation increases upon DM expression others are clearly edited out from the peptidome.

摘要

主要组织相容性复合体 II(MHCII)免疫肽组代表了具有激活 CD4 T 细胞潜力的抗原肽库。了解特定抗原表位的相对丰度如何影响 T 细胞反应的结果是适应性免疫的一个重要方面,并为在疾病背景下更合理地调整 T 细胞激活提供了途径。质谱仪器、计算能力、标记策略和软件分析的最新进展使得 HLA 配体组在基础和转化研究方面的分层研究数量不断增加。在 MHCII 免疫肽组的情况下,一个关键挑战是从长度可变的抗原肽中得出共识表位的定量信息,这些免疫肽组通常是针对不同条件下的不同样本确定的。在这里,我们提出了一种新算法(肽景观抗原表位对齐实用程序(PLAtEU))的设计和基准测试,该算法允许从一系列嵌套肽中识别和无标记定量(LFQ)共享共识表位。该算法简化了数据集的复杂性,同时允许在相对较短的蛋白质序列段内识别嵌套肽。此外,我们将该算法应用于比较具有两种不同肽交换催化剂 HLA-DM 表达水平的细胞系的配体组。在肽水平上直接比较 LFQ 强度的结果是不确定的,因为由于采样不佳,大多数肽没有显著富集。应用 PLAtEU 算法将肽分组为共识表位表明,超过一半的总表位数对于每种条件都是优先且显著富集的。这种对复杂且模糊的肽水平数据集的简化和解卷积突出了 PLAtEU 算法在促进跨细胞背景下免疫肽组的稳健和可访问的定量分析方面的价值。对每种 HLA-DM 表达条件下富集的肽进行分析表明,从高 DM 表达样本中分离的肽池中肽的亲和力更高。有趣的是,我们的分析表明,虽然某些与自身免疫相关的表位在 DM 表达时会增加,但其他表位显然已从肽组中编辑掉了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/e4a090dc3084/fimmu-09-00872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/d407352faf08/fimmu-09-00872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/f882d246d12c/fimmu-09-00872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/d54f5872fdf3/fimmu-09-00872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/caa3611f98e9/fimmu-09-00872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/db8b1a84d402/fimmu-09-00872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/e4a090dc3084/fimmu-09-00872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/d407352faf08/fimmu-09-00872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/f882d246d12c/fimmu-09-00872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/d54f5872fdf3/fimmu-09-00872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/caa3611f98e9/fimmu-09-00872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/db8b1a84d402/fimmu-09-00872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbd3/5943503/e4a090dc3084/fimmu-09-00872-g006.jpg

相似文献

1
Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.利用肽景观抗原表位比对工具定量 HLA-DM 依赖的主要组织相容性复合物 II 免疫肽组。
Front Immunol. 2018 May 3;9:872. doi: 10.3389/fimmu.2018.00872. eCollection 2018.
2
Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4 T cell activation.天然 HLA-DM 同种异型的独特编辑功能影响抗原呈递和 CD4 T 细胞激活。
Cell Mol Immunol. 2020 Feb;17(2):133-142. doi: 10.1038/s41423-018-0181-1. Epub 2018 Nov 22.
3
Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.基于抗原切割、MHCII 呈递和 TCR 识别预测 CD4 T 细胞表位。
PLoS One. 2018 Nov 6;13(11):e0206654. doi: 10.1371/journal.pone.0206654. eCollection 2018.
4
Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.使用细胞因子捕获抗原呈递细胞鉴定 HLA Ⅰ类和 HLA Ⅱ类限制性 T 细胞受体的抗原。
Sci Immunol. 2021 Jan 22;6(55). doi: 10.1126/sciimmunol.abf4001.
5
Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.鉴定洗脱的主要组织相容性复合体 II 类配体的预测性切割基序。
Front Immunol. 2018 Aug 6;9:1795. doi: 10.3389/fimmu.2018.01795. eCollection 2018.
6
Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.不变链作为一种载体,将抗原肽加载到人 MHC Ⅰ类分子上,用于细胞毒性 T 细胞的激活。
Eur J Immunol. 2014 Mar;44(3):774-84. doi: 10.1002/eji.201343671. Epub 2013 Dec 27.
7
Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A in C57BL/6 Mouse Thymus.在对稀缺生物样本的免疫肽组学研究中区分信号与噪声:C57BL/6 小鼠胸腺中 I-A 呈递的肽。
Front Immunol. 2021 Apr 29;12:658601. doi: 10.3389/fimmu.2021.658601. eCollection 2021.
8
Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.有序和无序蛋白区域中的表位分布-第 A 部分。T 细胞表位频率、亲和力和亲水性。
J Immunol Methods. 2014 Apr;406:83-103. doi: 10.1016/j.jim.2014.02.012. Epub 2014 Mar 12.
9
A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.一种基于肽结合竞争测定和差异 IC(50)测定的测量与 MHC Ⅱ类分子结合的肽的 HLA-DM 易感性的新方法。
J Immunol Methods. 2014 Apr;406:21-33. doi: 10.1016/j.jim.2014.02.008. Epub 2014 Feb 25.
10
A population response analysis approach to assign class II HLA-epitope restrictions.一种用于指定II类HLA表位限制的群体反应分析方法。
J Immunol. 2015 Jun 15;194(12):6164-6176. doi: 10.4049/jimmunol.1403074. Epub 2015 May 6.

引用本文的文献

1
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
2
FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells.FASTMAP:一种基于人工抗原呈递细胞的 HLA 和抗原特异性 T 细胞表位作图的灵活且可扩展的免疫肽组学管道。
Front Immunol. 2024 May 8;15:1386160. doi: 10.3389/fimmu.2024.1386160. eCollection 2024.
3
CD4+ T Cell Epitope Identification from Complex Parasite Antigen Mixtures.

本文引用的文献

1
The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines.人类单核细胞中的主要组织相容性复合体II类抗原呈递途径因亚群而异,并受细胞因子调节。
PLoS One. 2017 Aug 23;12(8):e0183594. doi: 10.1371/journal.pone.0183594. eCollection 2017.
2
Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides.揭示人类白细胞抗原DQ2.5与II类相关恒定链肽异常丰富关联的结构基础。
J Biol Chem. 2017 Jun 2;292(22):9218-9228. doi: 10.1074/jbc.M117.785139. Epub 2017 Mar 31.
3
Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
从复杂寄生虫抗原混合物中鉴定 CD4+ T 细胞表位。
Methods Mol Biol. 2023;2673:89-109. doi: 10.1007/978-1-0716-3239-0_6.
4
MHC Class II Presentation in Autoimmunity.主要组织相容性复合体 II 类分子在自身免疫中的呈递。
Cells. 2023 Jan 14;12(2):314. doi: 10.3390/cells12020314.
5
The Autophagy Receptor TAX1BP1 (T6BP) improves antigen presentation by MHC-II molecules.自噬受体 TAX1BP1(T6BP)可改善 MHC-II 分子的抗原呈递。
EMBO Rep. 2022 Dec 6;23(12):e55470. doi: 10.15252/embr.202255470. Epub 2022 Oct 10.
6
Natural variation of ncHLAII molecules: challenges and perspectives.非经典人类白细胞抗原II类分子的自然变异:挑战与展望。
Cell Mol Immunol. 2022 Dec;19(12):1432-1434. doi: 10.1038/s41423-022-00910-0. Epub 2022 Aug 26.
7
1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs.1,2,3,主要组织相容性复合体:基于质谱的免疫肽组学方法用于pMHC相对和绝对定量的综述
Immunooncol Technol. 2021 Oct 13;11:100042. doi: 10.1016/j.iotech.2021.100042. eCollection 2021 Oct.
8
Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome.调控 MHC II 免疫肽库可塑性的分子决定因素。
Front Immunol. 2022 May 16;13:878271. doi: 10.3389/fimmu.2022.878271. eCollection 2022.
9
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers.靶向新抗原以诱导针对癌症的T细胞免疫的治疗性疫苗。
Pharmaceutics. 2022 Apr 15;14(4):867. doi: 10.3390/pharmaceutics14040867.
10
Tuning DO:DM Ratios Modulates MHC Class II Immunopeptidomes.调节 DO:DM 比值可调节 MHC Ⅱ类免疫肽组。
Mol Cell Proteomics. 2022 Mar;21(3):100204. doi: 10.1016/j.mcpro.2022.100204. Epub 2022 Jan 25.
1 型糖尿病相关 HLA-DQ 分子的肽组学分析及 HLA-DM 对肽库编辑的影响。
Eur J Immunol. 2017 Feb;47(2):314-326. doi: 10.1002/eji.201646656. Epub 2016 Dec 13.
4
Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.直接从类风湿性关节炎或莱姆关节炎患者的滑膜组织、滑液或外周血临床样本中鉴定出的具有免疫原性的 HLA-DR 呈递的自身肽段。
J Proteome Res. 2017 Jan 6;16(1):122-136. doi: 10.1021/acs.jproteome.6b00386. Epub 2016 Nov 7.
5
Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.自身免疫性疾病中的人类白细胞抗原-DM多态性
Open Biol. 2016 Aug;6(8). doi: 10.1098/rsob.160165.
6
Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.从少量临床样本中鉴定人类白细胞抗原(HLA)-DR结合肽的方法。
Mol Cell Proteomics. 2016 Sep;15(9):3017-29. doi: 10.1074/mcp.M116.060764. Epub 2016 Jul 24.
7
The Perseus computational platform for comprehensive analysis of (prote)omics data.Perseus 计算平台,用于全面分析(蛋白质组学)数据。
Nat Methods. 2016 Sep;13(9):731-40. doi: 10.1038/nmeth.3901. Epub 2016 Jun 27.
8
Immunology by numbers: quantitation of antigen presentation completes the quantitative milieu of systems immunology!免疫学中的数字游戏:抗原呈递的定量分析完成了系统免疫学的定量环境!
Curr Opin Immunol. 2016 Jun;40:88-95. doi: 10.1016/j.coi.2016.03.007. Epub 2016 Apr 6.
9
Variations in MHC Class II Antigen Processing and Presentation in Health and Disease.MHC Ⅱ类抗原加工和呈递在健康和疾病中的差异。
Annu Rev Immunol. 2016 May 20;34:265-97. doi: 10.1146/annurev-immunol-041015-055420. Epub 2016 Feb 22.
10
Accounting for the Multiple Natures of Missing Values in Label-Free Quantitative Proteomics Data Sets to Compare Imputation Strategies.考虑无标记定量蛋白质组学数据集中缺失值的多重性质以比较插补策略。
J Proteome Res. 2016 Apr 1;15(4):1116-25. doi: 10.1021/acs.jproteome.5b00981. Epub 2016 Mar 1.